- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05135247
Cardiac Autonomic Modulation in Older Hypertensive Individuals Submitted to Different Types of Physical Training
Study Overview
Detailed Description
The individuals were randomized into four groups: continuous aerobic training (CA), interval aerobic training (IA), resistance training (R), and control (C), which performed physical exercises three times a week for twelve weeks, with a total of 36 sessions. The tilt test was performed before and after the research protocol. Individuals in the control group were only encouraged to maintain their usual activities.
For the analysis of HRV, the baseline conditions (resting in the supine position) were determined, followed by the passive postural maneuver, which characterizes the tilt test (table til tat 70 °) in order to determine the following variables:
- HR: heart rate (sympathetic action)
- LF: Low frequency band (Modulated predominantly by the sympathetic system)
- HF: High frequency band (Modulated predominantly by the parasympathetic system)
- Entropy: data complexity or irregularity index showing that, the higher the values, the better the HRV.
- DFAα1 (short term detrended fluctuation analysis)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:men and women 60-year-old or older, extensively using prescription antihypertensive drugs, and having no previous experience with physical training -
Exclusion Criteria:
• Positive treadmill test (TT) for ischemia
- Related left ventricular systolic dysfunction of any degree
- Presence of arrhythmias
- Use of β-blockers
- Use more than seven doses of ethyl alcohol per week
- Renal insufficiency
- Diabetes
- Hyper- or hypothyroidism
- Limiting lung disease
- Osteomioarticular impairment that would limit exercise performance
- SBP ≥160 and/or DBP ≥ 100 mmHg on baseline
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: continuous aerobic training (CA)
The CA group was trained with 70% of maximum heart rate (MHR) for 30 minutes.
|
3 different types of training or control
|
EXPERIMENTAL: resistance training (R)
The R sessions consisted of a set of each proposed exercise: sitting bench press, legpress, back row, leg extension, shoulders high pull, seated leg curl, biceps curls, standing calf, triceps in the pulley, and abdominal crunches, with 8 - 10 repetitions with 75% 1MR.
|
3 different types of training or control
|
EXPERIMENTAL: interval aerobic training (IA)
The IA group was submitted to exercise intensities of 60% for 2 minutes and 80% for 2 minutes, alternately, with a total of 30 minutes.
|
3 different types of training or control
|
NO_INTERVENTION: control (C)
Individuals in the control group maintained their usual activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart rate
Time Frame: 12 weeks
|
Heart rate was obtained before and after the protocol by electrocardiogram, performed before and after tilt test at each time.
|
12 weeks
|
Low frequency band
Time Frame: 12 weeks
|
Low frequency band was obtained before and after the protocol by electrocardiogram, performed before and after tilt test at each time.The electrical signal from the electrocardiogram was filtered and amplified.
The amplified signals were processed by ananalog-digital converter (DI-720, DATAQ Instruments, Akron, OH, USA) and sampled (1000 hz per channel) by a computer program (Windaq, DATAQ, Akron, OH, USA) installed in an IBM/PC computer.
|
12 weeks
|
High frequency band
Time Frame: 12 weeks
|
High frequency band was obtained before and after the protocol by electrocardiogram, performed before and after tilt test at each time.The electrical signal from the electrocardiogram was filtered and amplified.
The amplified signals were processed by ananalog-digital converter (DI-720, DATAQ Instruments, Akron, OH, USA) and sampled (1000 hz per channel) by a computer program (Windaq, DATAQ, Akron, OH, USA) installed in an IBM/PC computer.
|
12 weeks
|
Entropy
Time Frame: 12 weeks
|
Entropy was obtained before and after the protocol by electrocardiogram, performed before and after tilt test at each time.The electrical signal from the electrocardiogram was filtered and amplified.
The amplified signals were processed by ananalog-digital converter (DI-720, DATAQ Instruments, Akron, OH, USA) and sampled (1000 hz per channel) by a computer program (Windaq, DATAQ, Akron, OH, USA) installed in an IBM/PC computer.
|
12 weeks
|
Short term detrended fluctuation analysis
Time Frame: 12 weeks
|
Short term detrended fluctuation analysis obtained before and after the protocol by electrocardiogram, performed before and after tilt test at each time.The electrical signal from the electrocardiogram was filtered and amplified.
The amplified signals were processed by ananalog-digital converter (DI-720, DATAQ Instruments, Akron, OH, USA) and sampled (1000 hz per channel) by a computer program (Windaq, DATAQ, Akron, OH, USA) installed in an IBM/PC computer.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1.092.824
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autonomic Dysfunction
-
Kent State UniversityUnknownEndothelial Dysfunction | Autonomic DysfunctionUnited States
-
Northwell HealthEnrolling by invitationAutonomic Nervous System Diseases | Autonomic Dysfunction | Autonomic Imbalance | Vagus Nerve Autonomic DisorderUnited States
-
Virginia Polytechnic Institute and State UniversityNot yet recruiting
-
University of Mississippi Medical CenterVicor Technologies, Inc.CompletedAutonomic DysfunctionUnited States
-
St. Jude Children's Research HospitalRecruitingChildhood Cancer | Autonomic DysfunctionUnited States
-
The Cleveland ClinicCompleted
-
National Institute of Mental Health and Neuro Sciences...DyAnsys, Inc.; Vision Group on Science and TechnologyCompleted
-
Kansas City Heart Rhythm Research FoundationKansas City Heart and Rhythm Institute, Overland Park, KS; Bariatric and Metabolic...RecruitingOrthostatic Intolerance | Autonomic DysfunctionUnited States
-
CNSystems Medizintechnik GmbHNot yet recruitingOrthostatic Intolerance | Autonomic Dysfunction
-
Dana-Farber Cancer InstituteAmgenTerminatedLymphoma | Autonomic Imbalance | Cancer SurvivorshipUnited States
Clinical Trials on Exercise
-
University of Kansas Medical CenterRecruiting
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of
-
University of AlbertaWomen and Children's Health Research Institute, CanadaRecruitingType 1 Diabetes | Post-menopauseCanada
-
Uskudar UniversityCompleted
-
Yuksek Ihtisas UniversityCompletedDementia | Frailty | Cognitive Function | Reaction Time | Aerobic Exercise | Balance ExerciseTurkey
-
National Taiwan Normal UniversityCompletedAging | Cognitive DeclineTaiwan
-
Wayne State UniversityUnknown